home / stock / sera / sera news


SERA News and Press, Sera Prognostics Inc. From 11/13/22

Stock Information

Company Name: Sera Prognostics Inc.
Stock Symbol: SERA
Market: NASDAQ
Website: seraprognostics.com

Menu

SERA SERA Quote SERA Short SERA News SERA Articles SERA Message Board
Get SERA Alerts

News, Short Squeeze, Breakout and More Instantly...

SERA - Sera Prognostics, Inc. (SERA) Q3 2022 Earnings Call Transcript

Sera Prognostics, Inc. (SERA) Q3 2022 Earnings Conference Call November 9, 2022, 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - President and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly -...

SERA - Sera Prognostics GAAP EPS of -$0.35

Sera Prognostics press release ( NASDAQ: SERA ): Q3 GAAP EPS of -$0.35. Revenue of $87,000 compared to $23,000 for the same period of 2021. Total operating expenses were $11.3 million, up from $9.5 million for the third quarter of 2021. For further detail...

SERA - SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Nov. 9, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by pro...

SERA - Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), ...

SERA - SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS

SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS PR Newswire The value created by applying Sera's PreTRM® test and treat strategy ...

SERA - BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS

BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS PR Newswire First and only broadly clinically validated test to provide accurate and actionable information to help reduce the morbidity, mortality, and costs associate...

SERA - Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q2 2022 Earnings Call Aug 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript

SERA - Sera Prognostics, Inc. (SERA) CEO Greg Critchfield on Q2 2022 Results - Earnings Call Transcript

Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Conference Call August 10, 2022 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners Greg Critchfield - Chairman, President & Chief Executive Officer Jay Moyes - Chief Financial Officer Confere...

SERA - Sera Prognostics GAAP EPS of -$0.37 beats by $0.03, revenue of $0.07M misses by $0.02M

Sera Prognostics press release ( NASDAQ: SERA ): Q2 GAAP EPS of -$0.37 beats by $0.03 . Revenue of $0.07M (+250.0% Y/Y) misses by $0.02M . For further details see: Sera Prognostics GAAP EPS of -$0.37 beats by $0.03, revenue of $0.07M misses by $0.02M

SERA - SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Aug. 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing inn...

Previous 10 Next 10